A new CBS poll released on 4/20 is the first to show majority female support for marijuana legalization in the US. Though still trailing the 59% of men who are in favor of legalization, 54% of women now say they support it too.
Last year’s CBS poll found that only 43% of women were pro-legalization, versus 54% of men, an 11-point gap. This year’s poll narrows the gap to 5 points and represents an 11% jump in support from women in only one year’s time.
National polls in recent years have shown women’s support for legalization as high as 48%, but always trailing men’s approval by 8-13 points. Women are also around 15% less likely to admit that they have tried marijuana.
The same is true regionally: in Florida a 2015 Quinnipac poll found again 57% of men supported legalization and only 46% of women did. And if marijuana were to be legalized for recreational use in the state, 70 percent of women said they would ‘definitely not use’ it, compared to 59 percent of men.
Similarly in Ohio, there was a 12% differential between men at 59% support and women at 47%; and 71 percent of women, and only 57 percent of men, said they would ‘definitely not use’ legal marijuana.
But now perhaps we have reached a tipping point on women coming over to seeing the light of legalization. When I checked in January of this year, Cal NORML’s Twitter followers were 75% male, down from 85% a few months earlier; they’re now down to 66% male, a 20% drop in less than 6 months.
One reason for the shift, I think, is the increased number of female leaders at NORML chapters across the country, changing the perception of what a marijuana enthusiast looks like and giving women voters a greater comfort zone to voice their own support. A quick list of those leaders compiled by NORML Outreach Coordinator Kevin Mahmalji are:
- Eleanore Ahrens – Southeast Ohio NORML
- Vera Allen – Minnesota NORML
- Trish Bertrand – Springfield NORML
- Roseann Boffa – Los Angeles NORML
- Cara Bonin – Houston NORML
- Jes Bossems – Jefferson Area, Virginia NORML
- Monica Chavez – New Mexico NORML
- Cynthia Ferguson – Delaware NORML
- Jax Finkle – Texas NORML
- Karen Goldstein – Florida NORML
- Kandice Hawes – Orange County, California NORML
- Laura Judy – National Office
- Jamie Kacz – Kansas City NORML
- Danielle Keane – National Office
- Ellen Komp – California NORML
- Jessica Lee – Nacogdoches NORML
- Jenni Morgan – National Office
- Cher Neufer – Ohio NORML
- Theresa Nightingale – Pittsburgh NORML
- Danica Noble – NORML Women of Washington
- Pam Novy – Virginia NORML
- Jenn Michelle Pedini – Richmond NORML
- Jordan Person – Denver NORML
- Sharron Ravert – Peachtree, Georgia NORML
- Carrie Satterwhite – Wyoming NORML
- Mary Smith – Toledo NORML
- Jessica Struzik – Northern Wisconsin NORML
- Danielle Vitale – O’Brien – Miami Valley, Ohio NORML
- Destiny Young – San Antonio NORML
Women everywhere are getting the message. “It is not as harmful as alcohol … It also helps medical conditions as a more natural substitute to pharmaceuticals,” one 46-year-old woman told Pew pollsters in 2015. “I think crime would be lower if they legalized marijuana,” said another woman, aged 62. “It would put the drug dealers out of business.”
Campaigns directed at women in states with legalization measures seem to have had an effect. Only 49 percent of women polled in favor of Colorado’s 2012 legalization measure, but 53 percent of them voted for it. The majority of women voters in Washington State also voted in favor of that state’s measure to legalize.
Many people are aware that women helped bring about alcohol prohibition in 1919. What many don’t know is that women were also instrumental in repealing prohibition, notably Pauline Sabin, the Republican socialite for whom NORML’s award recognizing women’s leadership is named. It seems that women are now also key in bringing about marijuana legalization.
Fifty-six percent of Americans say “Marijuana use should be legal,” according to the results of a nationwide poll commissioned by CBS News. The percentage is the highest ever reported by news agency.
Only 36 percent of respondents said that they opposed legalization.
Seventy-one percent of respondents between the ages of 18 and 34 said that marijuana use ought to be legal, an increase of 10 percent since CBS posed the question last year. Among those age 35 to 64, 57 percent of respondents backed legalization, while only 31 percent of those age 65 or older did so.
Men (59 percent) were more likely than women (54 percent) to support making marijuana use legal. Democrats (63 percent) and Independents (58 percent) were far more likely to support legalization compared to Republicans (44 percent).
In response to a separate polling question, 51 percent of Americans admitted having consumed cannabis, up from 34 percent in 1997.
The poll possesses a margin of error of +/- four percent.
The CBS survey results are similar to those of other recent national polls, such as those by reported by Gallup, CBS, and Pew, finding that a majority of Americans now support ending marijuana prohibition.
During an appearance in South Carolina over the weekend, Hillary Clinton endorsed amending marijuana from it’s current Schedule I classification, reserved for the most dangerous of drugs, to Schedule II, a lesser classification intended for drugs that have recognized medical applications but also have a high potential for abuse and severe psychological or physical dependence.
The presidential candidate said, “What I do want is for us to support research into medical marijuana because a lot more states have passed medical marijuana than have legalized marijuana, so we’ve got two different experiences or even experiments going on right now. And the problem with medical marijuana is there’s a lot of anecdotal evidence about how well it works for certain conditions, but we haven’t done any research. Why? Because it’s considered what’s called a Schedule I drug, and you can’t even do research on it.”
Let’s take a look at these statements a little more closely.
First, Clinton’s claim that “we haven’t done any research” on cannabis’ safety and potential efficacy is false. NORML documents hundreds of relevant trials here. Clinton’s allegation is further rebutted by the findings of a 2012 review of FDA-approved clinical trials involving the use of herbal cannabis in various patient populations, “Based on evidence currently available the Schedule I classification is not tenable; it is not accurate that cannabis has no medical value, or that information on safety is lacking.”
Second, while Clinton’s comments mark an evolution in her position on marijuana policy, she is late to the game among the presidential candidates proposing policy solutions to marijuana’s prohibition. Fellow democrat presidential candidate, Martin O’Malley previously pledged to use his executive authority, if elected, to move marijuana from Schedule I to Schedule II. And Republican presidential candidate Rand Paul is a sponsor of the CARERS Act, legislation that, among other things, would also move marijuana from Schedule I to Schedule II.
Third, while all of these statements by presidential candidates is a step in the right direction, NORML has and will continue to advocate for marijuana’s removal from the federal Controlled Substances Act. Rescheduling marijuana from I to II would not limit the federal government’s authority to prosecute marijuana offenders, including those who are in compliance with state law, nor would it likely stimulate clinical trial research trials beyond those studies funded by the US National Institute on Drug Abuse and reliant upon government-grown marijuana.
Fortunately, Vermont Senator and Democrat Presidential candidate, Bernie Sanders has introduced legislation to remove marijuana from the US Federal Controlled Substances Act. The Ending Federal Marijuana Prohibition Act of 2015 would deschedule cannabis from the CSA, similar to alcohol and tobacco. It would also allow states the power to establish their own marijuana policies and banking policies free from federal interference.
Reform advocates can contact their member of the US Senate in support of The Ending Federal Marijuana Prohibition Act of 2015 by clicking here.
Fifty-five percent of registered voters believe that the personal use of marijuana should be legal, according to national tracking poll data compiled by Morning Consult – a Washington DC consulting firm. Thirty-eight percent of respondents polled said that they oppose legalization and eight percent were undecided.
Majorities of both men (57 percent) and women (52 percent) said that they support legalization. Among registered voters between the ages of ages of 18 and 44, over 60 percent endorse legalizing cannabis.
Majorities of both Democrats (63 percent) and Independents (59 percent) support legalization, according to the poll, while most Republicans (58 percent) do not.
The Morning Consult polling data is similar to those of other recent national polls, such as those by reported by Gallup, CBS News, and Pew, finding that a majority of Americans now support ending marijuana prohibition.
States that permit qualified patients to access medical marijuana via dispensaries possess lower rates of opioid addiction and overdose deaths, according to a study published by the National Bureau of Economic Research, a non-partisan think-tank.
Researchers from the RAND Corporation and the University of California, Irvine assessed the impact of medical marijuana laws on problematic opioid use, as measured by treatment admissions for opioid pain reliever addiction (compiled from the years 1992 to 2012) and by state-level opioid overdose deaths (compiled from the years 1999 to 2013).
“[S]tates permitting medical marijuana dispensaries experience a relative decrease in both opioid addictions and opioid overdose deaths compared to states that do not,” authors reported. They found that women over the age of 40 showed the most significant decrease in problematic opioid use.
Data published last year in the Journal of the American Medical Association (JAMA) Internal Medicine reported that the enactment of statewide medicinal marijuana laws is associated with significantly lower state-level opioid overdose mortality rates. “States with medical cannabis laws had a 24.8 percent lower mean annual opioid overdose mortality rate compared with states without medical cannabis laws,” investigators reported.
Overdose deaths involving opioid analgesics have increased dramatically over the past decade. While fewer than 4,100 opiate-induced fatalities were reported for the year 1999, by 2010 this figure rose to over 16,600 according to an analysis by the US Centers for Disease Control.
An abstract of the study, “Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?”, is available online here.